Showing results (81-90 of 94) with videos related to

Sort By:
Pageof 10
Blood|July 1, 2004
An association of candidate gene haplotypes and bleeding severity in von Willebrand disease (VWD) type 1 pedigreesThomas J Kunicki, Augusto B Federici, Daniel R Salomon, et al.
Blood|February 25, 2009
Identification and characterization of a novel P2Y 12 variant in a patient diagnosed with type 1 von Willebrand disease in the European MCMDM-1VWD studyMartina E Daly, Ban B Dawood, William A Lester, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|April 17, 2004
Management of von Willebrand disease: a guideline from the UK Haemophilia Centre Doctors' OrganizationK J Pasi, P W Collins, D M Keeling, et al.
Oncology Reports|June 26, 2008
A phase II clinical trial of gemcitabine and split dose cisplatin in advanced non-small cell lung cancer in an outpatient settingS A Hussain, D H Palmer, D E Swinson, et al.
Blood Advances|July 8, 2018
The common VWF single nucleotide variants c.2365A>G and c.2385T>C modify VWF biosynthesis and clearanceAhmad H Mufti, Kenichi Ogiwara, Laura L Swystun, et al.
British Journal of Haematology|June 5, 2003
Incidence and prognosis of c-KIT and FLT3 mutations in core binding factor (CBF) acute myeloid leukaemiasRory S Care, Peter J M Valk, Anne C Goodeve, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|April 7, 2005
A framework for genetic service provision for haemophilia and other inherited bleeding disordersC A Ludlam, K J Pasi, P Bolton-Maggs, et al.
Thrombosis Research|July 24, 2010
Validation of a rapid test (VWF-LIA) for the quantitative determination of von Willebrand factor antigen in type 1 von Willebrand disease diagnosis within the European multicenter study MCMDM-1VWDG Castaman, A Tosetto, A Cappelletti, et al.
Thrombosis and Haemostasis|May 25, 2013
Identification and characterisation of mutations associated with von Willebrand disease in a Turkish patient cohortDaniel J Hampshire, Adel M Abuzenadah, Ashley Cartwright, et al.
Thrombosis and Haemostasis|May 6, 1998
Factor VIII inhibitors in mild and moderate-severity haemophilia A. UK Haemophilia Centre Directors OrganisationC R Hay, C A Ludlam, B T Colvin, et al.
Pageof 10